A Study of TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy

Clinical trial NCT01290731 · COMPLETED

Trial details

NCT number: NCT01290731
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2011-01-01
Primary completion: 2012-08-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.